Skip to main content
. 2025 Jan 24;45(1):33. doi: 10.1007/s10792-024-03392-3

Table 2.

Plasma contents of cytokines in myopic CNV and control groups

Control CNV p valued
VEGF-A (pg/mL) 14.94 ± 11.57 l 42.61 ± 34.36 0.000
VEGF-C (pg/mL) 7.50 ± 2.72 21.08 ± 79.01 0.592
VEGF-D (pg/mL) 76.15 ± 39.11 58.95 ± 46.83 0.291
EGF (pg/mL) 1.13 ± 0.60 0.74 ± 0.35 0.011
Angiopoietin-2 (pg/mL) 1242.91 ± 347.91 897.71 ± 366.29 0.010
Endoglin (pg/mL) 1222.63 ± 298.57 1125.43 ± 497.07 0.559
FGF-1 (pg/mL) 10.42 ± 1.54 23.54 ± 70.32 0.561
FGF-2 (pg/mL) 22.84 ± 8.29 28.37 ± 20.84 0.418
IL-8 (pg/mL) 3.84 ± 2.87 4.60 ± 3.95 0.570
HGF (pg/mL) 200.70 ± 123.95 139.34 ± 72.24 0.056
HB-EGF (pg/mL) 9.84 ± 7.18 14.10 ± 19.98 0.513
PLGF (pg/mL) 9.44 ± 4.36 8.28 ± 6.46 0.594

VEGF vascular endothelial growth factor, EGF epidermal growth factor, FGF fibroblast growth factor, IL-8 interleukin-8, HGF hepatocyte growth factor, HB-EGF heparin-binding epidermal growth factor, PLGF placental growth factor

dT test between control and myopic CNV groups for plasma contentss of cytokines